Brief: Atossa Therapeutics - On August 30, Intas Pharmaceuticals Ltd Filed A Petition For Post Grant Review With U.S. Patent And Trademark Office
Aug 31 (Reuters) - Atossa Therapeutics Inc ATOS.O :
* ATOSSA THERAPEUTICS - ON AUGUST 30, INTAS PHARMACEUTICALS
LTD
FILED A PETITION FOR POST GRANT REVIEW WITH U.S. PATENT AND
TRADEMARK OFFICE
* ATOSSA THERAPEUTICS- INTENDS TO CONTEST PGR PETITION AND
BELIEVES THAT PATENT WAS PROPERLY GRANTED AND IS VALID AND
ENFORCEABLE
* ATOSSA THERAPEUTICS - PGR PETITION RELATING TO ONE OF
CO'S
ISSUED PATENTS TITLED, "METHODS FOR MAKING AND USING ENDOXIFEN"
Source: [https://shorturl.at/FHO17]
Further company coverage: ATOS.O
Recent news on Atossa Therapeutics
See all newsAtossa Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Atossa Therapeutics Q3 net loss narrows as clinical trial expenses decline
Brief: Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation In Potential Priority Review Voucher Value
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
Atossa Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary